Xceleron Inc Company Profile, Contacts & Intelligence

Xceleron Inc Overview

Xceleron offers a combination of technology and experimental design you won’t find anywhere else. Throughout the development continuum, Xceleron provides analytical solutions to help you answer questions before they become issues and invaluable foresight to navigate the road ahead. Xceleron’s use of Accelerator Mass Spectrometry (AMS) technology delivers solutions and insight for a range of pharmaceutical challenges. Xceleron believes that AMS technology and our expertise can get life-changing products quickly and cost-effectively to people who need them. We work with integrity and an open mind and are driven by science and the spirit of collaboration. Founded in 1997 in York, UK, and now headquartered in Germantown, Maryland, Xceleron pioneered human microdose and microtracer techniques using AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I, and Phase II/III clinical trials. Xceleron’s experience is especially valuable because the characteristics of many contemporary small molecules (low solubility, long half-life and disproportionate human metabolites) mean that their early pharmacokinetic and metabolic characterization is critical to the cost-effectiveness of clinical development.

Headquarters

Germantown, Md, United States

Website

xceleron.com

Industry

Biotechnology Research

Founded

1997

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Phone Number

Available in AeroLeads

Company Email

Available in AeroLeads

Xceleron Inc Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Xceleron Inc Workforce Composition

Seniority breakdown across 5 visible profiles.

Compare Similar Companies to Xceleron Inc

Explore companies in related markets and compare their industry and employee estimates.